Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Whole Genome And Exome Sequencing Market Today And What Is Its Future Size?

The scaling of the entire genome and exome sequencing market has been exponential in the past few years. It is anticipated to increase from $2.02 billion in 2024 to $2.52 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 24.5%. This surge in the historical phase can be credited to reducing sequencing expenses, increasing genetic diseases, clinical usage, the growth of genomic data repositories and advancements in bioinformatics.

A significant surge in the market size of whole genome and exome sequencing is anticipated in the forthcoming years, predicted to rise to $6.11 billion by 2029, boasting a compound annual growth rate (CAGR) of 24.8%. The estimated growth during the forecast period can be linked to factors such as the initiatives in population genomics, an escalating need for precision medicine, developments in single-cell sequencing, broadening of non-invasive prenatal testing (NIPT), and its application in rare disease research. Key trends expected during the prediction period encompass extended clinical adoption, swift evolution in sequencing technologies, emergence of large-scale genomic studies, amalgamation of artificial intelligence (AI) and machine learning (ML), and extensive applications in oncology.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

Which Key Factors Are Fueling Growth In The Whole Genome And Exome Sequencing Market?

The anticipated surge in personalized medicine is speculated to boost the expansion of the whole genome and exome sequencing market. Personalized medicine refers to a healthcare approach that customizes medical treatment to each patient’s individual characteristics, taking into account their genetics, environment, and lifestyle. Whole genome and exome sequencing plays a role in personalized medicine by offering an in-depth exploration of a person’s genetic profile, facilitating healthcare decisions and interventions tailored to their distinctive genetic, environmental, and lifestyle influences. For example, the Personalized Medicine Coalition (PMC), a US organization that fosters the comprehension and application of personalized medicine, predicted in October 2022 that over 75,000 genetic testing products and 300 personalized medicines are set to enter the market in 2022. Moreover, the Center for Drug Evaluation and Research (CDER) under the Food and Drug Administration gave green light to 37 new molecular entities (NMEs) in 2022. Of the 35 therapeutic NMEs, roughly 34% or 12 of these are categorized as personalized. Hence, the escalating demand for personalized medicine is propelling the evolution of the whole genome and exome sequencing market.

How Is The Whole Genome And Exome Sequencing Market Segmented Across Key Categories?

The whole genome and exome sequencingmarket covered in this report is segmented –

1) By Product Type: Kits; Instruments

2) By Workflow: Whole Genome Sequencing (WGS); Whole Exome Sequencing (WES)

3) By Applications: Diagnostics; Cancer; Monogenic Disorders; Diabetes; Drug Discovery And Development; Personalized Medicine; Agriculture And Animal Research; Other Applications

4) By End user: Research Center; Academic And Government Institutions; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users

Subsegments:

1) By Kits: Library Preparation Kits; Target Enrichment Kits; DNA Extraction Kits

2) By Instruments: Next-Generation Sequencing (NGS) Systems; Sanger Sequencing Systems; Third-Generation Sequencing Systems

What Key Trends Are Driving Growth In The Whole Genome And Exome Sequencing Market?

Leading companies in the whole genome and exome sequencing markets are shifting their attention to the development of cutting-edge technology solutions, such as ultra-rapid next-generation sequencing (NGS) analysis, in a bid to achieve a competitive advantage. The ultra-fast NGS analysis is a ground-breaking tech breakthrough that facilitates the processing of NGS data at an unprecedented speed, drastically cutting down the time needed for genomic data analysis. For example, QIAGEN Digital Insights (QDI), a bioinformatics firm based in the US, unveiled the ultra-fast NGS analysis platform in January 2023. The platform’s features include processing an entire genome in 25 minutes at a cloud computing cost of $1, thereby enhancing efficiency, cost-effectiveness, and scalability. This revolutionary technology significantly boosts the speed and accessibility of genomic data analysis, playing a crucial role in the whole genome and exome sequencing market by enabling swift decision-making and broader implementation of personalized medicine.

Who Are The Leading Companies Driving The Whole Genome And Exome Sequencing Market?

Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

Which Region Dominates The Whole Genome And Exome Sequencing Market Today?

North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13957&type=smp

Browse Through More Reports Similar to the Global Whole Genome And Exome Sequencing Market 2025, By The Business Research Company

Ngs Based Rna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Prenatal Dna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report

Whole Exome Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model